Identification | Back Directory | [Name]
FMOC-LYS(ME3)-OH HCL | [CAS]
201004-29-7 | [Synonyms]
Fmoc-Lys(Me) 3-OH Chloride Fmoc-Lys(Me)3-OH Cl FMOC-LYS(ME3)-OH HCL FMOC-L-LYS(ME3)-OH CL FMOC-LYS(ME)3-OH CHLORIDE FMoc-L-Lys(Me)3-OH chloride FMOC-LYSINE(ME)3-OH CHLORIDE FMOC-LYS(ME3)-OH HCL USP/EP/BP Fmoc-Lys(Me)3-OH hydrochloride Fmoc-Lys(Me3)-OH.chloride, >97% Nα-Fmoc-Nε-(trimethyl)-L-lysine chloride Fmoc-N',N',N'-trimethyl-L-lysine chloride FMOC-N-EPSILON-(TRIMETHYL)-L-LYSINE CHLORIDE Nα-Fmoc-Nε-(trimethyl)-L-lysine chloride≥ 98% (HPLC) (9H-Fluoren-9-yl)MethOxy]Carbonyl Lys(Me)3-OH Chloride N-ALPHA-FMOC-N-EPSILON,EPSILON,EPSILON-TRIMETHYL-L-LYSINE CHLORIDE N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-N',N',N'-trimethyl-L-lysine chloride 5-carboxy-5-(9H-fluoren-9-ylmethoxycarbonylamino)pentyl]-trimethylazanium,chloride N-ALPHA-(9-FLUORENYLMETHYLOXYCARBONYL)-N-EPSILON-TRIMETHYLAMONIUM-L-LYSINE CHLORIDE N-ALPHA-(9-FLUOROENYLMETHYLOXYCARBONYL)-N-EPSILON-TRIMETHYLAMONIUM-L-LYSINE CHLORIDE N-ALPHA-(9-FLUORENYLMETHOXYCARBONYL)-N-EPSILON,N-EPSILON,N-EPSILON-TRIMETHYL-L-LYSINE CHLORIDE [(5S)-5-carboxy-5-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)pentyl]trimethylazanium hydrochloride (5S)-5-Carboxy-5-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-N,N,N-trimethyl-1-pentanaminium chloride (1:1), 97% REF DUPL: (S)-2-(((9H-fluoren-9-yl)methyl9H-fluoren-9-yl)methoxy)carbonylamino)-6-(dimethylamino)hexanoic acid hydrochloride | [Molecular Formula]
C24H31N2O4.Cl | [MDL Number]
MFCD01861330 | [MOL File]
201004-29-7.mol | [Molecular Weight]
446.97 |
Chemical Properties | Back Directory | [storage temp. ]
-15°C | [solubility ]
Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | [form ]
Powder | [color ]
White to yellow |
Hazard Information | Back Directory | [Chemical Properties]
White to off-white powder | [Uses]
Fmoc-Lys(Me)3-OH chloride is one of the common N-terminal protected reagents used in the peptide synthesis. Some of the reported examples are:
- Synthesis of peptide linkers for monoclonal antibody-auristatin F conjugates.
- Preparation of multifunctional reagents with enhanced ionization properties for the analysis of protein modification in human cells and dynamic profiling of protein lipidation.
- Sequential peptide ligation to synthesize histone H3 containing a trimethyl lysine residue, with modified tail region.
| [General Description]
Fmoc protected N-trimethyl lysine |
|
|